Urothelial Cancer
In unresectable/metastatic urothelial carcinoma, upfront nivolumab/chemotherapy prolongs survival
SG Tylor
Source –Bristol-Myers Squibb Nivolumab plus chemotherapy showed statistically significant and clinically meaningful improvements in progression-free survival (PFS) and overall survival ...
